Analysts: Takeda Pharmaceutical Co Ltd (4502.T)

4502.T on Tokyo Stock Exchange

4,832JPY
10:30pm EDT
Price Change (% chg)

¥5 (+0.10%)
Prev Close
¥4,827
Open
¥4,830
Day's High
¥4,868
Day's Low
¥4,830
Volume
1,416,600
Avg. Vol
1,918,515
52-wk High
¥5,170
52-wk Low
¥4,396

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -- March 16 Sep 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 1 2 3 3
(3) HOLD 11 10 10 11
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.77 2.69 2.64 2.67

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Mar-14 16 1,677,400.00 1,700,200.00 1,593,700.00 --
Year Ending Mar-15 13 1,725,920.00 1,750,000.00 1,680,000.00 1,708,680.00
Year Ending Mar-16 13 1,794,590.00 1,825,000.00 1,748,000.00 1,784,960.00
Earnings (per share)
Year Ending Mar-14 16 142.81 202.00 119.00 --
Year Ending Mar-15 14 121.24 146.00 102.80 131.37
Year Ending Mar-16 14 148.13 184.30 120.30 167.58
LT Growth Rate (%) 2 13.25 17.30 9.20 4.85

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-14 442,083.00 411,148.00 30,935.00 7.00
Quarter Ending Mar-14 411,700.00 404,810.00 6,890.00 1.67
Quarter Ending Dec-13 447,600.00 458,532.00 10,932.00 2.44
Quarter Ending Sep-13 422,800.00 418,041.00 4,759.00 1.13
Quarter Ending Jun-13 392,750.00 410,302.00 17,552.00 4.47

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Mar-14 1,677,400.00 -- -- -- --
Year Ending Mar-15 1,725,920.00 1,725,920.00 1,729,750.00 1,725,080.00 1,708,680.00
Year Ending Mar-16 1,794,590.00 1,794,590.00 1,798,470.00 1,790,410.00 1,784,960.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Mar-14 -- -- -- --
Year Ending Mar-15 0 0 0 0
Year Ending Mar-16 0 0 0 0
Earnings

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters StreetEvents
$75.00
Provider: MarketLine (a Datamonitor Company)
$175.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks